RTALB 株式概要 RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
報酬 リスク分析 +1 さらなるリスク
すべてのリスクチェックを見る RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. 競合他社 価格と性能
の歴代最高値、変動、値下がりまとめRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret 過去の株価 現在の株価 ₺17.18 52週高値 ₺32.56 52週安値 ₺10.45 ベータ -0.078 11ヶ月の変化 -7.54% 3ヶ月変化 52.44% 1年変化 29.95% 33年間の変化 93.52% 5年間の変化 2,015.41% IPOからの変化 1,210.86%
最新ニュース
Third quarter 2024 earnings released: EPS: ₺0.26 (vs ₺0.47 in 3Q 2023) Nov 02
Second quarter 2024 earnings released: ₺1.95 loss per share (vs ₺0.76 profit in 2Q 2023) Sep 20
Investor sentiment deteriorates as stock falls 24% Sep 17
Investor sentiment improves as stock rises 20% Sep 03
New minor risk - Share price stability Aug 19
Investor sentiment improves as stock rises 17% Aug 14 最新情報をもっと見る
Third quarter 2024 earnings released: EPS: ₺0.26 (vs ₺0.47 in 3Q 2023) Nov 02
Second quarter 2024 earnings released: ₺1.95 loss per share (vs ₺0.76 profit in 2Q 2023) Sep 20
Investor sentiment deteriorates as stock falls 24% Sep 17
Investor sentiment improves as stock rises 20% Sep 03
New minor risk - Share price stability Aug 19
Investor sentiment improves as stock rises 17% Aug 14
First quarter 2024 earnings released Jun 13
Now 21% undervalued after recent price drop May 24
New minor risk - Financial data availability May 17
Now 21% undervalued after recent price drop May 07
Now 21% undervalued after recent price drop Mar 13
Investor sentiment improves as stock rises 22% Dec 05
Investor sentiment deteriorates as stock falls 16% Oct 12
Investor sentiment improves as stock rises 16% Sep 11
Investor sentiment improves as stock rises 20% Aug 16
Second quarter 2023 earnings released Aug 14
Investor sentiment improves as stock rises 17% Jun 01
Full year 2022 earnings released Mar 16
Investor sentiment improves as stock rises 17% Mar 09
Investor sentiment deteriorates as stock falls 18% Feb 01
Investor sentiment deteriorated over the past week Jan 05
Investor sentiment improved over the past week Nov 28
Insufficient new directors Nov 16
Investor sentiment improved over the past week Oct 10
Second quarter 2022 earnings released: EPS: ₺0.59 (vs ₺0.39 in 2Q 2021) Aug 21
Investor sentiment improved over the past week Jul 15
Investor sentiment improved over the past week Jun 30
Investor sentiment improved over the past week Jun 15
First quarter 2022 earnings released: EPS: ₺0.78 (vs ₺0.60 in 1Q 2021) May 12
Insufficient new directors Apr 27
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 13
Investor sentiment deteriorated over the past week Feb 24
Investor sentiment improved over the past week Nov 30
Third quarter 2021 earnings released Nov 12
Investor sentiment improved over the past week Sep 08
Second quarter 2021 earnings released Aug 24
First quarter 2021 earnings released: EPS ₺0.60 (vs ₺0.24 in 1Q 2020) Jun 12
Investor sentiment deteriorated over the past week Apr 17
Investor sentiment improved over the past week Mar 29
Full year 2020 earnings released: EPS ₺1.49 (vs ₺0.15 in FY 2019) Mar 13
Investor sentiment deteriorated over the past week Feb 23
New 90-day low: ₺25.66 Feb 19
New 90-day low: ₺28.08 Jan 18
New 90-day low: ₺33.08 Dec 24
Investor sentiment deteriorated over the past week Dec 16
New 90-day low: ₺40.28 Dec 07
Third quarter 2020 earnings released: EPS ₺0.34 Nov 08
Market bids up stock over the past week Oct 29
New 90-day high - ₺59.20 Aug 25
First half earnings released Aug 14
New 90-day high - ₺51.85 Aug 07 株主還元 RTALB TR Biotechs TR 市場 7D 2.0% 2.3% -1.3% 1Y 30.0% -3.4% 3.6%
株主還元を見る
業界別リターン: RTALB過去 1 年間で-3.4 % の収益を上げたTR Biotechs業界を上回りました。
リターン対市場: RTALB過去 1 年間で3.6 % の収益を上げたTR市場を上回りました。
価格変動 Is RTALB's price volatile compared to industry and market? RTALB volatility RTALB Average Weekly Movement 15.4% Biotechs Industry Average Movement 8.0% Market Average Movement 6.1% 10% most volatile stocks in TR Market 9.1% 10% least volatile stocks in TR Market 4.5%
安定した株価: RTALBの株価は過去 3 か月間にわたって変動しています。
時間の経過による変動: RTALBの 週次ボラティリティ は、過去 1 年間で10%から15%に増加しました。
会社概要 RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.はトルコで微生物学と分子生物学製品の研究、開発、生産に従事している。シャーレ、チューブ、ボトル、発色培地、血液培養ボトル、結核診断、迅速検査、微生物染色、ハイギスライド、サーチェック培地、メンブレン、スワブ製品などの微生物学製品、核酸分離キット、リアルタイムPCRキット、ボルトランウイルス量検出システムなどの分子生物学製品を提供。同社は1996年に法人化され、トルコのコチェリに拠点を置く。
もっと見る RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. 基礎のまとめ RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret の収益と売上を時価総額と比較するとどうか。 RTALB 基礎統計学 時価総額 ₺1.73b 収益（TTM） ₺88.72m 売上高(TTM ) ₺107.40m
収益と収入 最新の決算報告書（TTM）に基づく主な収益性統計 RTALB 損益計算書（TTM） 収益 ₺107.40m 売上原価 ₺76.17m 売上総利益 ₺31.23m その他の費用 -₺57.49m 収益 ₺88.72m
一株当たり利益（EPS） 0.89 グロス・マージン 29.08% 純利益率 82.61% 有利子負債／自己資本比率 11.1%
RTALB の長期的なパフォーマンスは？
過去の実績と比較を見る
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
